Harry Glorikian is a globally recognized expert at the intersection of healthcare, data science, and emerging technologies. With over three decades of experience, he has had a front-row seat to the real-time evolution of healthcare—transforming cutting-edge science into FDA-approved products, guiding Fortune 500 companies through digital transformation, and investing in startups that are reshaping the future of medicine.

As a General Partner at Scientia Ventures, Harry invests in visionary entrepreneurs who are leveraging computational biology and digital health innovations to revolutionize diagnostics, drug discovery, and patient care. Since 2017, companies in his portfolio have achieved successful IPOs and strategic acquisitions, reflecting his sharp eye for high-impact, scalable healthcare solutions.

Harry is also a seasoned technologist and operator, known for his ability to convert complex real-world data into actionable, trustworthy insights. In an industry where transparency, explainability, and precision are non-negotiable, his approach helps ensure both better patient outcomes and stronger investment returns.

Beyond the boardroom and lab, Harry is a committed communicator and thought leader. As the author of MoneyBall Medicine and The Future You, and host of The Harry Glorikian Show, he shares stories of innovators who are translating bold ideas into real-world healthcare breakthroughs.

Across all his roles—investor, operator, author, and podcast host—Harry’s mission remains constant: to leverage technology, strategy, and human ingenuity to lower healthcare costs while raising the standard of care globally.